Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: -0.25 (-3.33%)
Spread: 0.50 (7.143%)
Open: 7.55
High: 7.55
Low: 7.25
Prev. Close: 7.50
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kromek to produce ventilators to fight COVID-19

15 Apr 2020 07:00

RNS Number : 6476J
Kromek Group PLC
15 April 2020
 

15 April 2020

 

Kromek Group plc

("Kromek" or the "Group")

 

Kromek to commence production of Metran-based ventilators for COVID-19 response

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, is pleased to announce that it intends to commence the manufacture and sale of medical ventilators in the UK and globally under license from Metran Co., Ltd ("Metran"), a Japan-based leading developer of medical ventilator products and technology, to support the COVID-19 response.

 

Kromek expects to commence production of ventilators before the end of April 2020 and to produce up to 2,000 units within twelve weeks, with 1,000 units available within eight weeks. Following the signing of a license agreement, which is expected shortly, Kromek intends to sell the ventilators in the UK and globally.

 

For over 30 years, Metran has specialised in the development and manufacture of respiratory equipment, and it is Japan's leading ventilator manufacturer. Its ventilators offer an effective solution to the current crisis where ventilators need to be manufactured rapidly to meet public health demands.

 

Dr Arnab Basu, CEO of Kromek, said: "We have been working through the British Embassy in Japan with substantial help from the Department of International Trade and are delighted to be progressing this technology transfer. By combining our existing manufacturing skills with Metran's proven technology, we expect to commence the manufacture of these robust ventilators from next week and deliver in a rapid manner. Any procurement of this equipment from Kromek is expected to have the additional benefit of safeguarding and creating employment in the North East as well as contributing to this region's fight against COVID-19. We look forward to the ongoing relationship with Metran."

 

Dan Nitta, President of Metran, added: "We have seen an unprecedented demand for ventilation equipment in recent months. We realised at an early stage of this crisis that we needed to think beyond our in-house manufacturing capability if we were to make a substantial impact. Therefore, we reached out globally to find partners who could help us to expand our capacity, and we are pleased to form this relationship with Kromek. With a combination of Metran's experience in the ventilation field and Kromek's skill as a designer and manufacturer of advanced electronic equipment, we believe that we can make a substantial contribution to the fight against COVID-19."

 

This announcement contains inside information.

 

For further information, please contact:

 

Kromek Group plc

 

Arnab Basu, CEO

Derek Bulmer, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Broker)

 

Max Hartley (NOMAD)

Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon (PR)

 

Harry Chathli

Claire Norbury

Alexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

 

About Kromek Group plc

 

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

 

About Metran Co., Ltd

 

Metran is a manufacturer of medical devices specializing in the respiratory field. Our flagship product is the Humming series of neonatal ventilators, based on global best-in-class piston-based High Frequency Oscillation. We also manufacture CPAP devices, oxygen concentrators and provide contract R&D services. Metran's HQ is in Saitama, Japan, with a factory and R&D base in Ho Chi Minh, Vietnam. Metran currently has around 130 employees at its sites in Japan and Vietnam.

 

For more information about Metran, please visit our webpage at www.metran.co.jp

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSFFFALESSEDL
Date   Source Headline
29th Mar 20177:00 amRNSDirector/PDMR Shareholding
7th Mar 20177:00 amRNSAward of New Contract for Radiation Detectors
22nd Feb 20177:00 amRNSFive-Year Contract in Security Screening Market
15th Feb 20174:35 pmRNSHolding(s) in Company
15th Feb 201712:54 pmRNSHolding(s) in Company
15th Feb 201712:51 pmRNSHolding(s) in Company
14th Feb 20175:40 pmRNSHolding(s) in Company
14th Feb 20175:39 pmRNSHolding(s) in Company
14th Feb 20175:25 pmRNSDirector/PDMR Shareholding
14th Feb 20172:27 pmRNSHolding(s) in Company
14th Feb 201710:31 amRNSHolding(s) in Company
13th Feb 20172:04 pmRNSDirector/PDMR Shareholding
10th Feb 20173:19 pmRNSDirector/PDMR Shareholding
10th Feb 201711:51 amRNSResults of Firm Placing, Open Offer and GM
2nd Feb 20174:38 pmRNSHolding(s) in Company
1st Feb 20175:18 pmRNSHolding(s) in Company
26th Jan 201711:42 amRNSHolding(s) in Company
25th Jan 20177:00 amRNSFirm Placing and Open Offer to raise up to £21m
24th Jan 201710:15 amRNSTotal Voting Rights
22nd Dec 201611:05 amRNSSecond Price Monitoring Extn
22nd Dec 201611:00 amRNSPrice Monitoring Extension
7th Dec 20167:00 amRNSInterim Results
24th Nov 20162:15 pmRNSHolding(s) in Company
18th Nov 201612:15 pmRNSNotice of Results
2nd Nov 20167:00 amRNSNew BMD orders from existing OEM customers
19th Oct 20167:00 amRNSDelivery of 10,000 units of D3S to DARPA
17th Oct 20167:00 amRNSSix New Contract Wins Across All Business Segments
30th Sep 201612:22 pmRNSBlock listing Interim Review
21st Sep 201612:33 pmRNSResult of AGM
9th Sep 201611:46 amRNSBlock Admission
26th Aug 20163:24 pmRNSNotice of AGM and Posting of Annual Report
3rd Aug 20164:13 pmRNSHolding(s) in Company
1st Aug 20161:09 pmRNSPublication of Annual Report
29th Jul 201612:37 pmRNSTotal Voting Rights
20th Jul 201610:06 amRNSDirector/PDMR Shareholding
19th Jul 20167:00 amRNSFinal Results
23rd Jun 20167:00 amRNSHolding(s) in Company
28th Apr 20167:00 amRNSNew $12.6m contract with existing OEM customer
15th Apr 20161:27 pmRNSTotal Voting Rights
15th Apr 20161:25 pmRNSBlock listing Interim Review
14th Mar 20167:00 amRNSDirector Share Purchase
25th Feb 201611:12 amRNSHolding(s) in Company
22nd Feb 20167:00 amRNSSole source supplier contract from DARPA
22nd Feb 20167:00 amRNSKromek awarded further $748K contract by DARPA
18th Feb 20164:05 pmRNSHolding(s) in Company
4th Feb 20167:00 amRNSCapital Markets Day
20th Jan 20167:00 amRNSNew contract with long-standing customer
22nd Dec 201511:29 amRNSDirector Share Purchase
16th Dec 20157:00 amRNSDirectorate Changes
16th Dec 20157:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.